IL17A and neoplasm: Tregs in turn encourage tumor progression by releasing cytokines like TGFβ [67, 68] as well as IL17 [69–71], aiding in EMT and maintaining stemness [67, 68, 72], and under hypoxic conditions supporting angiogenesis by secreting VEGF [73].